These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32682887)

  • 41. Pigment-Synthesizing Melanocytic Neoplasm With Protein Kinase C Alpha (PRKCA) Fusion.
    Bahrami A; Lee S; Wu G; Kerstetter J; Rahvar M; Li X; Easton J; Zhang J; Barnhill RL
    JAMA Dermatol; 2016 Mar; 152(3):318-22. PubMed ID: 26676968
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The protein phosphatase 2A subunit Bgamma gene is identified to be differentially expressed in malignant melanomas by subtractive suppression hybridization.
    Deichmann M; Polychronidis M; Wacker J; Thome M; Näher H
    Melanoma Res; 2001 Dec; 11(6):577-85. PubMed ID: 11725204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
    Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
    Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
    [TBL] [Abstract][Full Text] [Related]  

  • 44. BRAF and NRAS mutations in melanoma and melanocytic nevi.
    Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
    Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subungual pigmented nevus: evaluation of DNA ploidy in six cases.
    Asahina A; Chi HI; Otsuka F
    J Dermatol; 1993 Aug; 20(8):466-72. PubMed ID: 8245307
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome.
    Greene MH; Clark WH; Tucker MA; Elder DE; Kraemer KH; Guerry D; Witmer WK; Thompson J; Matozzo I; Fraser MC
    N Engl J Med; 1985 Jan; 312(2):91-7. PubMed ID: 3964923
    [No Abstract]   [Full Text] [Related]  

  • 47. Patterns of melastatin mRNA expression in melanocytic tumors.
    Deeds J; Cronin F; Duncan LM
    Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heavily Pigmented Epithelioid Melanoma With Loss of Protein Kinase A Regulatory Subunit-α Expression.
    Cohen JN; Spies JA; Ross F; Bohlke A; McCalmont TH
    Am J Dermatopathol; 2018 Dec; 40(12):912-916. PubMed ID: 29771690
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phenotypic and histologic characteristics of cutaneous melanoma in patients with melanocortin-1 receptor polymorphisms.
    Avilés JA; Lázaro P; Fernández LP; Benítez J; Ibarrola-Villava M; Ribas G
    Actas Dermosifiliogr; 2012 Jan; 103(1):44-50. PubMed ID: 22464597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study.
    Dyduch G; Okoń K; Pescarini E
    Pol J Pathol; 2011 Sep; 62(3):139-44. PubMed ID: 22102069
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Morphometry of melanocytic skin lesions--verifications or vexations? A review of a group experience.
    Williams RA
    Pathologica; 1998 Apr; 90(2):183-5. PubMed ID: 9619064
    [No Abstract]   [Full Text] [Related]  

  • 52. Multiple complementary transcripts of pCMa1, a novel gene located at chromosome 11p15.1-2, and melanocytic cell transformation.
    Meije CB; Das PK; Jans MM; Hau C; van der Wal AC; Alders M; Hakvoort TB; Weidle UH; Lamers WH; Swart GW
    J Pathol; 2002 Aug; 197(5):668-76. PubMed ID: 12210088
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of New Techniques in Addition to IHC Applied to the Diagnosis of Melanocytic Lesions, With Emphasis on CGH, FISH, and Mass Spectrometry.
    Nagarajan P; Tetzlaff MT; Curry JL; Prieto VG
    Actas Dermosifiliogr; 2017; 108(1):17-30. PubMed ID: 27344067
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The DNA and sex chromatin in pigmented skin neoplasms in man].
    Naleskina LA
    Vopr Onkol; 1971; 17(4):8-14. PubMed ID: 5564886
    [No Abstract]   [Full Text] [Related]  

  • 55. BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin.
    Uribe P; Wistuba II; González S
    Am J Dermatopathol; 2003 Oct; 25(5):365-70. PubMed ID: 14501284
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human telomerase RNA component expression in Spitz nevi, common melanocytic nevi, and malignant melanomas.
    Guttman-Yassky E; Bergman R; Manov L; Sprecher E; Shaefer Y; Kerner H
    J Cutan Pathol; 2002 Jul; 29(6):341-6. PubMed ID: 12135464
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of oncogenic BRAF mutations and p16 expression on the growth rate of early melanomas and naevi in vivo.
    Tschandl P; Berghoff AS; Preusser M; Pammer J; Pehamberger H; Kittler H
    Br J Dermatol; 2016 Feb; 174(2):364-70. PubMed ID: 26613644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation.
    Meije CB; Hakvoort TB; Swart GW; Westerhof W; Lamers WH; Das PK
    J Pathol; 2002 Jan; 196(1):51-8. PubMed ID: 11748642
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unexpected High Levels of BRN2/POU3F2 Expression in Human Dermal Melanocytic Nevi.
    Chitsazan A; Lambie D; Ferguson B; Handoko HY; Gabrielli B; Walker GJ; Boyle GM
    J Invest Dermatol; 2020 Jun; 140(6):1299-1302.e4. PubMed ID: 31881210
    [No Abstract]   [Full Text] [Related]  

  • 60. Molecular diagnosis of a benign proliferative nodule developing in a congenital melanocytic nevus in a 3-month-old infant.
    Murphy MJ; Jen M; Chang MW; Grant-Kels JM; Makkar H
    J Am Acad Dermatol; 2008 Sep; 59(3):518-23. PubMed ID: 18640742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.